Northern Trust’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Sell |
409,353
-12,307
| -3% | -$537K | ﹤0.01% | 1711 |
|
|
2025
Q1 | $11.5M | Sell |
421,660
-16,173
| -4% | -$443K | ﹤0.01% | 1956 |
|
|
2024
Q4 | $17.6M | Buy |
437,833
+53,658
| +14% | +$2.16M | ﹤0.01% | 1777 |
|
|
2024
Q3 | $18.2M | Buy |
384,175
+16,034
| +4% | +$759K | ﹤0.01% | 1677 |
|
|
2024
Q2 | $11M | Sell |
368,141
-4,645
| -1% | -$139K | ﹤0.01% | 1938 |
|
|
2024
Q1 | $15M | Buy |
372,786
+14,207
| +4% | +$571K | ﹤0.01% | 1795 |
|
|
2023
Q4 | $9.13M | Sell |
358,579
-7,676
| -2% | -$195K | ﹤0.01% | 2134 |
|
|
2023
Q3 | $5.09M | Buy |
366,255
+11,327
| +3% | +$157K | ﹤0.01% | 2433 |
|
|
2023
Q2 | $8.16M | Buy |
354,928
+18,101
| +5% | +$416K | ﹤0.01% | 2210 |
|
|
2023
Q1 | $9.98M | Sell |
336,827
-4,614
| -1% | -$137K | ﹤0.01% | 2014 |
|
|
2022
Q4 | $8.52M | Buy |
341,441
+9,703
| +3% | +$242K | ﹤0.01% | 2117 |
|
|
2022
Q3 | $7.22M | Sell |
331,738
-1,640
| -0.5% | -$35.7K | ﹤0.01% | 2218 |
|
|
2022
Q2 | $6.56M | Buy |
333,378
+13,508
| +4% | +$266K | ﹤0.01% | 2330 |
|
|
2022
Q1 | $13.5M | Sell |
319,870
-19,030
| -6% | -$805K | ﹤0.01% | 1950 |
|
|
2021
Q4 | $21.5M | Buy |
338,900
+177
| +0.1% | +$11.2K | ﹤0.01% | 1712 |
|
|
2021
Q3 | $19.9M | Buy |
338,723
+79,208
| +31% | +$4.65M | ﹤0.01% | 1816 |
|
|
2021
Q2 | $12.6M | Buy |
259,515
+142,014
| +121% | +$6.89M | ﹤0.01% | 2218 |
|
|
2021
Q1 | $4.57M | Sell |
117,501
-4,425
| -4% | -$172K | ﹤0.01% | 2812 |
|
|
2020
Q4 | $7.56M | Buy |
+121,926
| New | +$7.56M | ﹤0.01% | 2431 |
|